谷歌浏览器插件

订阅小程序

在清言上使用

立即登录

学术主页个人账号

我的关注论文收藏浏览历史

A Phase 1b/2 Study Evaluating Efficacy and Safety of MP0250, a Designed Ankyrin Repeat Protein (darpin) Simultaneously Targeting Vascular Endothelial Growth Factor (VEGF) and Hepatocyte Growth Factor (HGF), in Combination with Bortezomib and Dexamethasone, in Patients with Relapsed or Refractory Multiple Myeloma

Stefan Knop,Monika Szarejko,Norbert Grzasko,Sara Bringhen,Karolin Trautmann-Grill,Artur Jurczyszyn,Angelo Vacca,Cyrus Khandanpour,Barbara Gamberi,Ludek Pour,Katrine F. Iversen,Michael T. Stumpp, Cosima Suter,Keith M. Dawson,Christof Zitt,Philippe Legenne,Vaia Stavropoulou,Martin F. Fey,Nicolas Leupin,Hartmut Goldschmidt

EJHAEM（2024）

引用 0|浏览5

关键词

anti-HGF,anti-VEGF,DARPin,MP0250,refractory/relapsed multiple myeloma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要